AUSTIN – A major pharmaceutical firm funneled kickbacks to Texas health officials, distributed false marketing materials and deployed phony advocacy groups to get its top-dollar schizophrenia drug prescribed* to low-income Texans, the state alleges in a new filing in a major fraud lawsuit. (*) Risperidal



No hay comentarios:
Publicar un comentario